Bevacizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
A Study of PRO95780 in Patients With Previously Untreated, Advanced-Stage Non-Small Cell Lung Cancer (APM4074g)
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Bevacizumab in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma (AMBER)
- Status
- COMPLETED
- Phase
- PHASE2
Enzastaurin, Carboplatin, and Gemcitabine With or Without Bevacizumab in Treating Patients With Recurrent, Stage IIIB, or Stage IV Non-Small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC
- Status
- COMPLETED
- Phase
- PHASE3
Study of Biweekly Capecitabine Dosing With Bevacizumab for the Treatment of Metastatic Breast Cancer Based Upon the Norton-Simon Mathematical Model
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Phase Ⅱ Clinical Study of R435 (Bevacizumab) in Combination With Paclitaxel in Patients With Inoperable Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Erlotinib and Bevacizumab in Treating Patients With Stage IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab and Irinotecan for Patients With Primary Brain Tumors and Progression After Standard Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab, Bevacizumab and Irinotecan for Patients With Malignant Glioblastomas
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy and Bevacizumab With or Without Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer
- Status
- COMPLETED
- Phase
- NA
Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Gemcitabine, Bevacizumab, and Abdominal Radiation Therapy in Treating Patients With Localized Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2